论文信息 - A three-outcome design for phase II clinical trials. - 字舞流文

A three-outcome design for phase II clinical trials.

D. Sargent | R. Goldberg | V. Chan

[1] J. Herndon,et al. A design alternative for two-stage, phase II, multicenter cancer clinical trials. , 1998, Controlled clinical trials.

[2] N Stallard,et al. Sample size determination for phase II clinical trials based on Bayesian decision theory. , 1998, Biometrics.

[3] J. Bryant,et al. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. , 1995, Biometrics.

[4] P. Thall,et al. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. , 1995, Statistics in medicine.

[5] B. Storer. A class of phase II designs with three possible outcomes. , 1992, Biometrics.

[6] R. Simon,et al. Optimal two-stage designs for phase II clinical trials. , 1989, Controlled clinical trials.

[7] T R Fleming,et al. One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.

[8] R. Simon,et al. Two-stage plans for patient accrual in phase II cancer clinical trials. , 1979, Cancer treatment reports.